
    
      In this clinical study, subjects will be implanted with the AcrySof IQ Vivity Extended Vision
      IOL in both eyes. The second eye surgery will occur 7-28 days after the first eye. A total of
      11 scheduled visits are planned, including a screening visit, two operative visits, and 8
      postoperative visits. The total expected duration of the subject's participation will be
      about 13 months. This study will be conducted in China.
    
  